Skip to main content

Wang Lab

The Wang lab is interested in developing drug leads/candidates for kinase, phosphate kinase and protein targets identified by UNC faculty and external investigators. We have successfully used the structure- and/or ligand-based drug design approaches to deliver compounds to clinic (MerTK inhibitors such as MRX-2843) or licensing (IDH1 inhibitor, co-developed with NCATs). We will continue to apply the similar approaches for drug discovery towards new targets.



Xiaodong Wang, PhD

Associate Professor, Chemical Biology and Medicinal Chemistry
Director of Medicinal Chemistry




Deyu Kong, PhD




Kaikai Lyu, PhD




Dilipkumar Uredi, PhD